Ze-min Lin

State Key Laboratory Of Drug Research
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

From Hit to Lead: Discovery of Novel Selective RIPK1 Inhibitor with Pyridoimidazole Scaffold for the Treatment of Autoimmune Diseases through Phenotypic Screening and Structural Optimization.

From Hit to Lead: Discovery of Novel Selective RIPK1 Inhibitor with Pyridoimidazole Scaffold for the Treatment of Autoimmune Diseases through Phenotypic Screening and Structural Optimization.

Journal: Journal of medicinal chemistry

Published: February 02, 2026

Androgen-type 2 innate lymphoid cells-dendritic cell axis modulates sex-associated differences in skin immune responses.

Androgen-type 2 innate lymphoid cells-dendritic cell axis modulates sex-associated differences in skin immune responses.

Journal: MedComm

Published: April 30, 2024

Interplay of IL-17A/IL-17RA signaling with microbial homeostasis in systemic anti-tumoral responses.

Interplay of IL-17A/IL-17RA signaling with microbial homeostasis in systemic anti-tumoral responses.

Journal: MedComm

Published: January 19, 2024

Highly modified cephalotane-type diterpenoids from Cephalotaxus fortunei var. alpina and C. sinensis.

Highly modified cephalotane-type diterpenoids from Cephalotaxus fortunei var. alpina and C. sinensis.

Journal: Phytochemistry

Published: December 03, 2023

Reversible SAHH inhibitor ameliorates MIA-induced osteoarthritis of rats through suppressing MEK/ERK pathway.

Reversible SAHH inhibitor ameliorates MIA-induced osteoarthritis of rats through suppressing MEK/ERK pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 10, 2023

ChatGPT for scientific paper writing-promises and perils.

ChatGPT for scientific paper writing-promises and perils.

Journal: Innovation (Cambridge (Mass.))

Published: September 04, 2023

NOD-like receptors in autoimmune diseases.

NOD-like receptors in autoimmune diseases.

Journal: Acta pharmacologica Sinica

Published: September 07, 2020

A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis.

A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis.

Journal: Acta pharmacologica Sinica

Published: September 04, 2020

The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling.

The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling.

Journal: Acta pharmacologica Sinica

Published: May 20, 2020

Cervus and cucumis peptides ameliorates bone erosion in experimental arthritis by inhibiting osteoclastogenesis.

Cervus and cucumis peptides ameliorates bone erosion in experimental arthritis by inhibiting osteoclastogenesis.

Journal: Lupus science & medicine

Published: March 12, 2019

Heme oxygenase-1 as a potential therapeutic target in rheumatic diseases.

Heme oxygenase-1 as a potential therapeutic target in rheumatic diseases.

Journal: Life sciences

Published: October 03, 2018

Spiroorthoester group-containing pregnane glycosides from the root barks of Periploca chrysantha and their inhibitory activities against the proliferation of B and T lymphocytes.

Spiroorthoester group-containing pregnane glycosides from the root barks of Periploca chrysantha and their inhibitory activities against the proliferation of B and T lymphocytes.

Journal: Bioorganic & medicinal chemistry letters

Published: November 02, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026